Iglu-A Oral Suspension Refreshing
By Iglu-A
Rx
170ml Oral Suspension in a Bottle

Composition
Magaldrate(480mg) + Simethicone(20mg) + Oxetacaine(10mg)

Manufacturer - Xenovia Health Care Pvt Ltd
FLAT NO 10-88 RUTVIK RESIDENCY INDIAN BANK BUILDING MEDIPALLY MEDCHAL MALKAJGIRI DISTRICT TELGANGANA 500039

Expires on or after
September, 2025

liver
Caution should be taken when considering the use of Iglu-A Oral Suspension Refreshing in individuals with liver disease. It is important to consult with your doctor before use, as there is limited information available on how this medication may affect those with liver conditions. Understanding the potential impact on the liver is crucial for your overall health and well-being. Your doctor will be able to provide guidance on whether Iglu-A Oral Suspension Refreshing is safe for you to use, considering your specific liver health. It is always best to seek medical advice to ensure your safety and minimize any risks associated with this medication.

kidney
Limited information exists regarding the use of Iglu-A Oral Suspension Refreshing in individuals with kidney disease. It is advised to consult your doctor before using this medication.

alcohol
It is advised not to consume alcohol while taking Iglu-A Oral Suspension Refreshing due to potential risks. Caution is advised during pregnancy.

driving
It is not clear if Iglu-A Oral Suspension Refreshing affects driving abilities. Avoid driving if you have symptoms that impact concentration or reaction time.

pregnancy
Information about the safe use of Iglu-A Oral Suspension Refreshing during pregnancy is not provided. It is best to consult your doctor before using this medication.

breastfeeding
It is better to consult your doctor before using Iglu-A Oral Suspension Refreshing.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹145
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024